Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-risk Myelodysplastic Syndromes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03459859
What this trial is testing

Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDS

Who this might be right for
Acute Myelogenous LeukemiaAMLAdvanced Myelodysplastic Syndromes+1 more
Justin Watts, MD 12
Testing effectiveness (Phase 2)Study completedNCT01015352
What this trial is testing

Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA)

Who this might be right for
Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 98
Testing effectiveness (Phase 2)Study completedNCT04477850
What this trial is testing

Evaluate the Efficacy, Drug Levels and Safety of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in Chinese and Japanese Participants With Ring Sideroblasts Who Require Red Blood Cell Transfusions

Who this might be right for
Myelodysplastic Syndromes
Celgene 30
Early research (Phase 1)Ended earlyNCT04810611
What this trial is testing

Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS

Who this might be right for
Myelodysplastic Syndromes
Novartis Pharmaceuticals 33
Early research (Phase 1)Ended earlyNCT01003678
What this trial is testing

Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients

Who this might be right for
Myelodysplastic Syndrome
Roswell Park Cancer Institute 4
Post-approval studies (Phase 4)Study completedNCT02145026
What this trial is testing

Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndromes
Hoffmann-La Roche 100
Not applicableNot Yet RecruitingNCT05433805
What this trial is testing

Lifestyle-modifying Interventions in Low-risk MDS Patients

Who this might be right for
Myelodysplastic Syndromes
Technische Universität Dresden 36
Not applicableLooking for participantsNCT06614595
What this trial is testing

Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS

Who this might be right for
Low Risk Myelodysplastic Syndromes
Fundación para la Investigación Biosanitaria del Principado de Asturias 30
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Early research (Phase 1)Study completedNCT00008177
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+14 more
Fred Hutchinson Cancer Center
Post-approval studies (Phase 4)Ended earlyNCT01326845
What this trial is testing

Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study

Who this might be right for
Myelodysplastic SyndromeTransfusional Iron Overload
Novartis Pharmaceuticals 12
Large-scale testing (Phase 3)Study completedNCT00322101
What this trial is testing

Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Myeloid Leukemia/Transient Myeloproliferative DisorderAdult Acute Myeloid Leukemia in Remission+16 more
Fred Hutchinson Cancer Center 25
Large-scale testing (Phase 3)Active Not RecruitingNCT06045689
What this trial is testing

Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Who this might be right for
Myelodysplastic Syndromes
Bristol-Myers Squibb 106
Testing effectiveness (Phase 2)Study completedNCT00516828
What this trial is testing

Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
NCIC Clinical Trials Group 21
Testing effectiveness (Phase 2)Ended earlyNCT00740181
What this trial is testing

Decitabine, Cytarabine, GCSF for Refractory AML/MDS

Who this might be right for
MyelodysplasiaLeukemia
Brown University 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07463820
What this trial is testing

A Trial Comparing Three Different Treatment Options for Adults With Low-Risk Myelodysplasia and Anemia (A MyeloMATCH Treatment Trial)

Who this might be right for
Myelodysplastic Syndrome
National Cancer Institute (NCI) 270
Testing effectiveness (Phase 2)Study completedNCT00812968
What this trial is testing

Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.

Who this might be right for
Myelodysplastic Syndromes
Celgene 11
Testing effectiveness (Phase 2)Study completedNCT00551291
What this trial is testing

NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.

Who this might be right for
Myelodysplastic Syndromes
Hoffmann-La Roche 10
Early research (Phase 1)Study completedNCT01062152
What this trial is testing

Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndrome
Telik 19
Testing effectiveness (Phase 2)WithdrawnNCT06020833
What this trial is testing

A Single-arm Trial of Roxadustat Combined With Retinoic Acid in the Treatment of Refractory Low-risk MDS

Who this might be right for
Myelodysplastic Syndromes
Peking Union Medical College Hospital
Next Page
79